Advanced Medical Solutions Group plc – Half Year 2026 Trading Update
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the innovative tissue-healing medical device company delivering high-performing solutions for better patient outcomes, today announces a trading update for the six months ended 30 June 2026.
The Board is pleased to announce that it expects to report half year 2026 revenues of approximately £115.2 million (H1 2025: £110.8 million), despite some first half orders shipping later than planned in early July. In addition, good progress in the Group’s strategic focus of expanding direct sales in Europe has led to some de-stocking, with a consequential impact on sales in the period. As reported in our preliminary results on 18 March 2026, first half performance was against a high comparator caused by order phasing of one key strategic partner in the Advance Closure division in H1 2025.
